"Sapienza" University of Rome, Department of Medico-surgical Sciences and Biotechnologies, Neurology Section, Rome, Italy.
Neurosci Lett. 2012 Oct 18;528(1):78-82. doi: 10.1016/j.neulet.2012.08.064. Epub 2012 Sep 7.
The purpose of this study was to shed light on the neurochemical modulatory mechanisms of the noxious spinal inhibitory cutaneous silent period (CSP). We study the effects of 100mg of oral tramadol in 11 healthy volunteers. Tramadol has low affinity for opioid receptors and has the ability to inhibit serotonin and noradrenaline reuptake. We elicited CSPs in the first dorsal interosseus muscle and noxious withdrawal flexor reflexes (NWR) in the right biceps femoris muscle before, 30 min and each hour up to the 6th after tramadol. Subjective pain sensation was checked on an 11-point numerical scale. Tramadol increased duration of CSP, and reduced the NWR area under the curve maximally 2h after tramadol and paralleled the reduction of subjective pain perception. We suggest that the monoaminergic action of tramadol reinforces the activity of spinal inhibitory interneurons on α-motoneurons for the hand muscles.
本研究旨在阐明伤害性脊髓抑制性皮肤静息期(CSP)的神经化学调制机制。我们研究了 11 名健康志愿者口服 100mg 曲马多的效果。曲马多对阿片受体的亲和力低,具有抑制 5-羟色胺和去甲肾上腺素再摄取的能力。我们在右侧股二头肌的第一背间骨肌中诱发出 CSP,并在曲马多之前、30 分钟和每小时至曲马多后 6 小时测量伤害性撤退屈肌反射(NWR)。使用 11 分制数字量表检查主观疼痛感觉。曲马多增加了 CSP 的持续时间,并最大程度地减少了 NWR 曲线下面积,在曲马多后 2 小时,这与主观疼痛感知的减少相平行。我们认为,曲马多的单胺能作用增强了手部肌肉α运动神经元上脊髓抑制性中间神经元的活性。